O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.97%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.28B
AUM Growth
+$8.28B
(+5.4%)
Cap. Flow
+$285M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
35.4%
Holding
137
New
11
Increased
41
Reduced
26
Closed
12
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$120M |
| 2 |
CELG
Celgene Corp
CELG
|
$110M |
| 3 |
SHPG
Shire pic
SHPG
|
$74.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
$73.6M |
| 5 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$60.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$156M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$123M |
| 3 |
Prothena Corp
PRTA
|
$72.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$60M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$57.6M |
Sector Composition
| 1 | Healthcare | 84.96% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
AngioDynamics
ANGO
$417M
| – | – | 0 | – | – |
|
127
AstraZeneca
AZN
$248B
| – | – | 0 | – | – |
|
|
BLUE
128
DELISTED
bluebird bio
BLUE
| – | – | -289,000 | Closed | -$6.57M |
|
129
Exelixis
EXEL
$10.1B
| – | – | -2,888,000 | Closed | -$10.2M |
|
130
iShares Biotechnology ETF
IBB
$5.6B
| – | – | 0 | – | – |
|
131
Inovio Pharmaceuticals
INO
$126M
| – | – | -3,987,000 | Closed | -$13.3M |
|